The Stalled Replication Fork
A cultured human fibroblast line is treated with hydroxyurea, which depletes dNTP pools and stalls replication forks. Within 30 minutes, immunofluorescence shows RPA32 foci in 60% of nuclei, and western blot shows phosphorylation of CHK1 at Ser345. After 2 hours, gamma-H2AX foci appear, but only in cells that had RPA32 foci earlier. A student proposes that RPA32 foci indicate double-strand breaks (DSBs) and that CHK1 phosphorylation is a downstream response to those breaks. A second student argues the order of events contradicts this. Separately, a titration experiment shows that 0.5 mM hydroxyurea gives 60% RPA-positive nuclei but only 10% gamma-H2AX-positive nuclei, while 5 mM gives 95% and 80%, respectively.
1. Evaluate the first student's interpretation using the temporal and dose data. What does RPA32 mark, and what is the more likely relationship between RPA32 foci and gamma-H2AX foci?
Read the worked answer
RPA32 is single-stranded DNA (ssDNA)-binding protein; foci mark regions of exposed ssDNA at stalled forks, not DSBs directly. The temporal order (RPA at 30 min, gamma-H2AX at 2 h, and only in cells previously RPA-positive) is consistent with stalled forks generating ssDNA first, and DSBs arising later when forks collapse. Dose-response supports this: low HU gives abundant ssDNA (60%) with little DSB signal (10%), while high HU saturates both. The correlation is not proof of causation, but the precedence and dose-discordance argue against RPA marking DSBs. The student's claim that RPA foci indicate DSBs is therefore unsupported; RPA marks ssDNA, and gamma-H2AX marks the later DSB response.
2. The second student claims CHK1 phosphorylation cannot be a response to DSBs because it precedes gamma-H2AX. Is this reasoning valid? Explain the signaling logic.
Read the worked answer
The reasoning is partly valid but overstated. ATR responds to RPA-coated ssDNA at stalled forks and phosphorylates CHK1 at Ser345; this is an early checkpoint response to replication stress, upstream of and independent of DSBs. Gamma-H2AX is a later marker, often ATM-dependent at DSBs. So CHK1 phosphorylation preceding gamma-H2AX is consistent with ATR signaling from ssDNA, not proof that DSBs are irrelevant. However, temporal precedence alone does not exclude a later DSB contribution. The correct conclusion: early CHK1 phosphorylation is best explained by ATR-RPA-ssDNA signaling; gamma-H2AX reflects subsequent fork collapse and DSB formation. The student should test with ATR or ATM inhibitors rather than rely on timing alone.
3. Design a control experiment to distinguish ssDNA accumulation from DSB formation at 0.5 mM hydroxyurea, and state expected outcomes.
Read the worked answer
Use ATR inhibition (e.g., VE-821) or ATR knockdown at 0.5 mM HU. If RPA foci are ssDNA from stalled forks, ATR inhibition should not abolish RPA foci but should reduce CHK1 Ser345 phosphorylation and accelerate fork collapse, increasing gamma-H2AX over time. Alternatively, label newly synthesized DNA with a short BrdU or EdU pulse and use native immunodetection of BrdU/EdU under non-denaturing conditions to visualize ssDNA directly; expected: ssDNA signal rises at 30 min at 0.5 mM HU without proportional gamma-H2AX. A neutral comet assay can quantify DSBs; expected low tail moment at 0.5 mM and higher at 5 mM. Together these separate ssDNA accumulation from DSB formation.